These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11698200)

  • 1. Chemokine-based therapies for MS: how do we get there from here?
    Kivisäkk P; Trebst C; Eckstein DJ; Kerza-Kwiatecki AP; Ransohoff RM
    Trends Immunol; 2001 Nov; 22(11):591-3. PubMed ID: 11698200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.
    Sellebjerg F; Sørensen TL
    Brain Res Bull; 2003 Aug; 61(3):347-55. PubMed ID: 12909304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
    Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
    J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges.
    Sadeghian-Rizi T; Khanahmad H; Jahanian-Najafabadi A
    CNS Neurol Disord Drug Targets; 2018; 17(7):496-508. PubMed ID: 30003862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and chemokine receptors in multiple sclerosis.
    Cheng W; Chen G
    Mediators Inflamm; 2014; 2014():659206. PubMed ID: 24639600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
    Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
    J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemokines and chemokine receptors in multiple sclerosis].
    Misu T; Fujihara K; Itoyama Y
    Nihon Rinsho; 2003 Aug; 61(8):1422-7. PubMed ID: 12962033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis.
    Liu MT; Keirstead HS; Lane TE
    J Immunol; 2001 Oct; 167(7):4091-7. PubMed ID: 11564831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cell migration into the central nervous system: a few new twists on an old tale.
    Man S; Ubogu EE; Ransohoff RM
    Brain Pathol; 2007 Apr; 17(2):243-50. PubMed ID: 17388955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking.
    Kivisäkk P; Trebst C; Liu Z; Tucky BH; Sørensen TL; Rudick RA; Mack M; Ransohoff RM
    Clin Exp Immunol; 2002 Sep; 129(3):510-8. PubMed ID: 12197893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.
    Ghafouri-Fard S; Honarmand K; Taheri M
    Metab Brain Dis; 2021 Mar; 36(3):375-406. PubMed ID: 33404937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis.
    Calabresi PA; Martin R; Jacobson S
    J Neurovirol; 1999 Feb; 5(1):102-8. PubMed ID: 10190696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.
    Sørensen TL; Tani M; Jensen J; Pierce V; Lucchinetti C; Folcik VA; Qin S; Rottman J; Sellebjerg F; Strieter RM; Frederiksen JL; Ransohoff RM
    J Clin Invest; 1999 Mar; 103(6):807-15. PubMed ID: 10079101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of chemokine signaling in patients with multiple sclerosis.
    Zipp F; Hartung HP; Hillert J; Schimrigk S; Trebst C; Stangel M; Infante-Duarte C; Jakobs P; Wolf C; Sandbrink R; Pohl C; Filippi M;
    Neurology; 2006 Nov; 67(10):1880-3. PubMed ID: 17130431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis.
    Eikelenboom MJ; Killestein J; Izeboud T; Kalkers NF; van Lier RA; Barkhof F; Uitdehaag BM; Polman CH
    J Neuroimmunol; 2002 Dec; 133(1-2):225-32. PubMed ID: 12446027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges.
    Trebst C; Ransohoff RM
    Arch Neurol; 2001 Dec; 58(12):1975-80. PubMed ID: 11735771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The best basic science paper in multiple sclerosis in 2014: important role for the choroid plexus in the central nervous system entry of leukocytes.
    Kooij G; de Vries HE
    Mult Scler; 2015 Apr; 21(4):372-3. PubMed ID: 25716882
    [No Abstract]   [Full Text] [Related]  

  • 18. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
    Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
    Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is damage in central nervous system due to inflammation?
    Chavarria A; Alcocer-Varela J
    Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.